MLAB

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +3.85
Percentage change 3.15	%

Peers: TMO MTD BRKR A BIO WAT IQV IDXX TECH COHR

| Held by: IJR VTI IWM VXF SPSM IJT IWN VTWO SCHA VIOO

Index	RUT	P/E	-	EPS (ttm)	-46.25	Insider Own	3.71%	Shs Outstand	5.43M	Perf Week	-8.26%
Market Cap	685.61M	Forward P/E	15.72	EPS next Y	8.03	Insider Trans	-3.16%	Shs Float	5.23M	Perf Month	-11.53%
Income	-249.44M	PEG	-	EPS next Q	1.91	Inst Own	94.27%	Short Float	3.80%	Perf Quarter	-2.08%
Sales	237.75M	P/S	2.88	EPS this Y	-17.80%	Inst Trans	4.36%	Short Ratio	5.33	Perf Half Y	5.53%
Book/sh	28.57	P/B	4.42	EPS next Y	4.12%	ROA	-42.32%	Short Interest	0.20M	Perf Year	18.51%
Cash/sh	5.70	P/C	22.15	EPS next 5Y	-0.95%	ROE	-89.38%	52W Range	83.68 - 155.12	Perf YTD	-4.31%
Dividend Est.	-	P/FCF	15.94	EPS past 5Y	-	ROI	-95.07%	52W High	-18.66%	Beta	0.91
Dividend TTM	0.64 (0.51%)	Quick Ratio	0.53	Sales past 5Y	16.61%	Gross Margin	55.53%	52W Low	50.79%	ATR (14)	6.49
Dividend Ex-Date	Feb 28, 2025	Current Ratio	0.71	EPS Y/Y TTM	-26360.70%	Oper. Margin	8.02%	RSI (14)	38.68	Volatility	5.02% 4.32%
Employees	736	Debt/Eq	1.36	Sales Y/Y TTM	11.68%	Profit Margin	-104.92%	Recom	2.50	Target Price	150.00
Option/Short	No / Yes	LT Debt/Eq	0.69	EPS Q/Q	-178.73%	Payout	-	Rel Volume	0.55	Prev Close	122.33
Sales Surprise	6.93%	EPS Surprise	58.06%	Sales Q/Q	17.52%	Earnings	Feb 04 BMO	Avg Volume	37.30K	Price	126.18
SMA20	-8.07%	SMA50	-9.14%	SMA200	3.33%	Trades		Volume	20,356	Change	3.15%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-24	Initiated	Wells Fargo	Underweight	$120
Jan-04-24	Upgrade	Evercore ISI	In-line → Outperform	$100 → $125
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line	$300
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$287
Oct-02-20	Initiated	JP Morgan	Neutral	$260
Dec-04-19	Initiated	Jefferies	Buy
Aug-26-19	Initiated	Evercore ISI	Outperform	$250
Jun-10-16	Downgrade	Sidoti	Buy → Neutral

Feb-13-25 08:31AM	What Makes Mesa Laboratories (MLAB) a Valuable Stock? (Insider Monkey)
Feb-11-25 12:20PM	Why Mesa Labs (MLAB) Might be Well Poised for a Surge (Zacks)
Feb-04-25 09:15AM	Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:17AM	Mesa Labs: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Mesa Labs Announces Third Quarter Results (GlobeNewswire)
01:15PM	Loading…
Jan-17-25 01:15PM	Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025 (GlobeNewswire)
Jan-06-25 03:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Nov-07-24 09:20AM	Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates (Zacks) -12.13%
08:27AM	Mesa Labs: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Mesa Labs Announces Second Quarter Results (GlobeNewswire)
Oct-15-24 05:02PM	Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc (GuruFocus.com)
Oct-02-24 02:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Aug-26-24 12:20PM	Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock (Zacks)
12:00PM	Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Aug-16-24 07:51AM	Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance (Insider Monkey)
08:15AM	Loading…
Aug-05-24 08:15AM	Mesa Labs: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Mesa Labs Announces First Quarter Results (GlobeNewswire)
Jul-31-24 09:14AM	Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2 (Insider Monkey)
Jul-08-24 02:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Jun-05-24 11:53AM	MLAB Stock Earnings: Mesa Laboratories Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace) +13.15%
06:38AM	Mesa Laboratories Posts Loss In Q4 (RTT News)
06:21AM	Mesa Labs: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results (GlobeNewswire)
May-31-24 06:00AM	Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results (GlobeNewswire) -13.41%
May-22-24 06:00AM	Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024 (GlobeNewswire)
Apr-08-24 08:00AM	MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES (GlobeNewswire) +5.17%
Apr-04-24 06:24PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Apr-01-24 10:27AM	Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024 (GlobeNewswire)
Mar-15-24 07:00AM	Mesa Labs Releases Second Annual Responsible Business Program Brochure (GlobeNewswire)
Feb-19-24 10:23AM	Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending (Insider Monkey)
09:20AM	Loading…
Feb-05-24 09:20AM	Mesa Labs (MLAB) Lags Q3 Earnings and Revenue Estimates (Zacks) +5.64%
08:36AM	Mesa Laboratories Inc (MLAB) Faces Revenue Dip Amidst Strategic Acquisitions (GuruFocus.com)
08:22AM	Mesa Labs: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Mesa Labs Announces Third Quarter Results (GlobeNewswire)
Jan-08-24 08:00AM	Mesa Laboratories Appoints Mark Capone to its Board of Directors (GlobeNewswire)
Jan-04-24 03:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Jan-03-24 08:00AM	Mesa Labs Completes the Acquisition of GKE Science & Technology Co. (GlobeNewswire) -8.59%
Dec-14-23 10:47AM	Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024 (GlobeNewswire) +6.12%
Nov-06-23 09:10AM	Mesa Laboratories Inc (MLAB) Reports 9.5% Decrease in Q2 FY 2024 Revenues (GuruFocus.com)
08:13AM	Mesa Labs: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Mesa Labs Announces Second Quarter Results (GlobeNewswire)
Oct-16-23 03:00AM	Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform (GlobeNewswire)
Oct-03-23 08:00AM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Sep-22-23 08:09AM	Penumbra and Mesa Labs have been highlighted as Zacks Bull and Bear of the Day (Zacks)
06:20AM	Bear of the Day: Mesa Labs (MLAB) (Zacks)
Sep-15-23 01:10AM	Insider Sell: Director John Schmieder Sells 3,000 Shares of Mesa Laboratories Inc (GuruFocus.com)
Sep-13-23 01:37PM	Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023 (GlobeNewswire)
Sep-11-23 11:21AM	15 Worst Performing Growth Stocks in 2023 (Insider Monkey)
Aug-24-23 04:02PM	Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions (GlobeNewswire)
Aug-10-23 01:32AM	Heres Why Mesa Laboratories (MLAB) Declined in Q2 (Insider Monkey)
Aug-03-23 09:35AM	Mesa Labs (MLAB) Surpasses Q1 Earnings Estimates (Zacks) +5.23%
08:27AM	Mesa Labs: Fiscal Q1 Earnings Snapshot (AP Finance)
08:00AM	Mesa Labs Announces First Quarter Results (GlobeNewswire)
Jul-31-23 07:50AM	Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Intrinsic Value Is Potentially 32% Above Its Share Price (Simply Wall St.)
Jul-05-23 03:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Jun-21-23 08:00PM	MLAB: Lowering target price to $138.00 (Argus Research)
11:50AM	Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023 (GlobeNewswire)
May-25-23 09:25AM	Mesa Labs (MLAB) Q4 Earnings and Revenues Miss Estimates (Zacks)
08:14AM	Mesa Labs: Fiscal Q4 Earnings Snapshot (AP Finance)
08:00AM	Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results (GlobeNewswire)
May-22-23 01:16PM	Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking (Simply Wall St.)
May-02-23 06:23AM	Mesa Laboratories (NASDAQ:MLAB) Is Reinvesting At Lower Rates Of Return (Simply Wall St.)
Apr-26-23 08:00PM	MLAB: Lowering target price to $169.00 (Argus Research)
Apr-03-23 06:15PM	Mesa Labs (MLAB) Stock Sinks As Market Gains: What You Should Know (Zacks)
06:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
07:42AM	Investors in Mesa Laboratories (NASDAQ:MLAB) have unfortunately lost 33% over the last year (Simply Wall St.)
Mar-13-23 08:00AM	Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure (GlobeNewswire)
Mar-09-23 08:00AM	Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023 (GlobeNewswire)
Feb-21-23 05:36AM	A Look At The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB) (Simply Wall St.)
Feb-14-23 09:00AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks) -7.32%
Feb-13-23 12:45PM	Is Mesa Labs (MLAB) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
08:00AM	Mesa Labs Releases Environmental, Social, and Governance Program Brochure (PR Newswire)
Feb-06-23 09:55AM	Mesa Labs (MLAB) Tops Q3 Earnings Estimates (Zacks) -9.08%
08:36AM	Mesa Labs Announces Third Quarter Results (GlobeNewswire)
Feb-01-23 12:43PM	What's in the Cards for Mesa Laboratories' (MLAB) Q3 Earnings? (Zacks)
06:43AM	Is Mesa Laboratories (MLAB) a Growing Stock? (Insider Monkey)
Jan-27-23 06:00PM	Mesa Labs (MLAB) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-19-23 06:15PM	Mesa Labs (MLAB) Gains As Market Dips: What You Should Know (Zacks)
Jan-17-23 04:33PM	Royce Investment Partners: Small-Cap Premier Quality Strategy--4Q22 Update and Outlook (GuruFocus.com)
Jan-13-23 06:00PM	Mesa Labs (MLAB) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-12-23 09:40AM	Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-11-23 06:26AM	Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) ROE Of 1.9% Concerning? (Simply Wall St.)
Jan-09-23 06:15PM	Mesa Labs (MLAB) Gains As Market Dips: What You Should Know (Zacks)
Jan-03-23 05:00PM	Mesa Labs Declares Quarterly Dividend (GlobeNewswire)
Dec-28-22 06:51AM	Mesa Labs and Eldorado Gold have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:20AM	Bull of the Day: Mesa Labs (MLAB) (Zacks)
Dec-18-22 04:48PM	Heres Why Mesa Laboratories (MLAB) Declined in Q3 (Insider Monkey)
Dec-16-22 11:59AM	Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023 (GlobeNewswire)
Nov-23-22 12:20PM	Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy? (Zacks)
Nov-17-22 08:04AM	Mesa Labs Acquires Belyntics Peptide Purification Business (GlobeNewswire)
Nov-08-22 06:48AM	Mesa Laboratories Second Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
Nov-04-22 03:49PM	Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director (GlobeNewswire) +9.86%
Nov-03-22 10:25AM	Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates (Zacks) +15.27%
08:00AM	Mesa Labs Announces Second Quarter Results (GlobeNewswire)
Oct-25-22 06:32AM	Further weakness as Mesa Laboratories (NASDAQ:MLAB) drops 7.8% this week, taking one-year losses to 60% (Simply Wall St.) +7.38%
Oct-03-22 02:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Sep-11-22 08:33AM	Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate (Simply Wall St.)
Aug-04-22 11:05AM	Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates (Zacks)
08:00AM	Mesa Labs Announces First Quarter Results (GlobeNewswire)
Jul-28-22 10:03AM	Mesa Labs (MLAB) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Owens Gary M	President and CEO	Oct 28 '24	Sale	113.62	2,518	286,085	45,888	Oct 29 08:18 PM
Owens Gary M	President and CEO	Oct 29 '24	Sale	111.98	2,551	285,651	43,337	Oct 29 08:18 PM
Owens Gary M	Officer	Oct 29 '24	Proposed Sale	111.98	2,551	285,652		Oct 29 03:47 PM
Owens Gary M	Officer	Oct 28 '24	Proposed Sale	113.62	2,518	286,086		Oct 28 03:12 PM
Archbold Brian David	SVP Operations	Sep 13 '24	Sale	125.00	1,499	187,375	0	Sep 16 12:14 PM
Archbold Brian David	Officer	Sep 13 '24	Proposed Sale	125.00	1,499	187,381		Sep 13 04:35 PM
Sakys John	CFO	Sep 01 '24	Option Exercise	0.00	1,037	0	12,500	Sep 06 12:46 PM
Owens Gary M	President and CEO	Sep 01 '24	Option Exercise	0.00	3,301	0	38,292	Sep 06 12:21 PM
Archbold Brian David	SVP Operations	Sep 01 '24	Option Exercise	0.00	845	0	1,885	Sep 06 12:12 PM
Sullivan John James	Director	Sep 01 '24	Option Exercise	0.00	1,074	0	27,878	Sep 06 11:53 AM
Tripeny R Tony	Director	Sep 01 '24	Option Exercise	0.00	1,074	0	2,679	Sep 06 11:43 AM
Ladiwala Shiraz Shabanali	Director	Sep 01 '24	Option Exercise	0.00	1,574	0	3,074	Sep 06 11:35 AM
Hall Shannon	Director	Sep 01 '24	Option Exercise	0.00	1,074	0	2,785	Sep 06 11:28 AM
Alltoft Jennifer Sadie	Director	Sep 01 '24	Option Exercise	0.00	1,074	0	3,474	Sep 06 11:22 AM
Capone Mark Christopher	Director	Aug 15 '24	Option Exercise	0.00	724	0	724	Aug 19 11:08 AM
Owens Gary M	President and CEO	Jun 14 '24	Option Exercise	0.00	4,959	0	34,991	Jun 17 01:41 PM
Archbold Brian David	SVP Operations	Jun 14 '24	Option Exercise	0.00	889	0	1,447	Jun 17 11:50 AM
Sakys John	CFO	Jun 14 '24	Option Exercise	0.00	1,304	0	12,035	Jun 17 11:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Mesa Laboratories, Inc

Upgrade your FINVIZ experience